Dimension (formerly The 2nd Dimension) — Seed & Series A VC Firm
Dimension (formerly The 2nd Dimension) is a Seed, Series A, Series B venture capital firm investing in Other, AI / ML, Developer Tools. The firm has 6 portfolio companies in our records.
- Portfolio
- 6 companies on record
- Partners
- 1 listed
- Stage
- Seed, Series A, Series B, Growth
- Sectors
- Other, AI / ML, Developer Tools
- Check size
- Not in our records
- AUM
- Not in our records
Seed, Series A, Series B, Growth
6+ companies
1 partner
Investment Thesis
Life sciences and technology fund backing companies across stages in biotech platforms, software infrastructure, lab tools, clinical development, manufacturing and commercialization, plus AI/ML.
How Dimension (formerly The 2nd Dimension) invests
Dimension (formerly The 2nd Dimension) is a vc firm. The firm invests at the Seed, Series A, Series B, Growth stages, with a focus on Other, AI / ML, Developer Tools.
Dimension (formerly The 2nd Dimension) has backed 6 companies in our records, including Atomic AI, Inceptive, Superluminal Medicines.
Partners & Team
Nan Li
Co-founder & Managing Partner
Industry Focus
Invests In
Portfolio Companies (6)
Other
Atomic AI
A biotechnology company combining machine learning and structural biology to predict RNA structures and design RNA-targeted small molecules and RNA therapeutics.
Inceptive
A biotechnology company developing "biological software" by using deep learning models to design novel, highly targeted RNA molecules.
Superluminal Medicines
A drug discovery company utilizing generative AI, machine learning, and structural biology to design small molecule therapeutics targeting G protein-coupled receptors (GPCRs).
Enveda Biosciences
A biotechnology company using AI, metabolomics, and mass spectrometry to identify and translate chemistry from natural products into new medicines.
Basecamp Research
A biotechnology company mapping global biodiversity to build a foundational dataset for designing novel proteins and enzymes using artificial intelligence.
Chroma Medicine
A genomic medicine company pioneering single-dose epigenetic editing therapeutics to regulate gene expression without altering the underlying DNA sequence.
- •Raising at Seed, Series A, Series B, Growth? You're squarely in their sweet spot.
- •Lead with your fit in Other, AI / ML, Developer Tools — the sectors they actively back.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Nan Li, Co-founder & Managing Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Dimension (formerly The 2nd Dimension) is a match for your startup
Upload your pitch deck to see how well you match with Dimension (formerly The 2nd Dimension) and 10,000+ other investors.
Is this your profile? Request a correction or removal